Avalyn Pharma Inc. (AVLN) vs Taysha Gene Therapies, Inc. (TSHA)
- Avalyn Pharma Inc. AVLN 27.88 −6.32%
- Taysha Gene Therapies, Inc. TSHA 4.01 −1.23%
Avalyn Pharma Inc. and Taysha Gene Therapies, Inc. are both Biotechnology companies. Avalyn Pharma Inc. and Taysha Gene Therapies, Inc. are of similar size ($1.3B and $1.2B). Across the 8 metrics below, Avalyn Pharma Inc. leads on 6 and Taysha Gene Therapies, Inc. on 2.
Valuation
Profitability
| Metric | AVLN | TSHA | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 70.18% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | (54.18%) | (50.72%) |
| Return on assets | 0.00% | (41.52%) | (45.56%) |
| Return on invested capital | (127.60%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack